Skip to main content

Bone Marrow Transplant clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for
  • Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMT CTN 1507)

    open to eligible people ages 5-45

    This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are stratified into two groups: (1) children with severe SCD; and (2) adults with severe SCD.

    Oakland, California and other locations

  • Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

    Sorry, in progress, not accepting new patients

    This is a clinical trial that will compare survival and sickle related outcomes in adolescents and young adults with severe sickle cell disease after bone marrow transplantation and standard of care. The primary outcome is 2-year overall survival.

    Oakland, California and other locations

Last updated: